How to Calculate the Concentration of Protein Using the BCA Assay

The bicinchoninic acid (BCA) assay is a colorimetric method for quantifying total protein concentration in solution, based on the reduction of Cu²⁺ to Cu⁺ by peptide bonds and the subsequent chelation of Cu⁺ by two molecules of BCA to form a purple-colored complex with maximum absorbance at 562 nm. This method is useful when you need a detergent-compatible, relatively accurate protein quantification across a broad concentration range (typically 20–2,000 µg/mL), particularly for samples containing reducing agents or chelating agents at low levels. The BCA assay is widely employed in laboratories for determining protein yields from cell lysates, purified protein fractions, and biological fluids, and has been validated as one of the most accurate methods for quantifying complex protein mixtures such as snake venoms [3].

At a Glance

Scientific Principle of the BCA Assay

The BCA assay operates through two sequential reactions. First, proteins in alkaline solution reduce Cu²⁺ (cupric ion) to Cu⁺ (cuprous ion) through the action of peptide bonds and specific amino acid side chains (cysteine, cystine, tryptophan, and tyrosine). The amount of Cu⁺ produced is proportional to the protein concentration. Second, each Cu⁺ ion is chelated by two molecules of BCA, forming a stable, water-soluble complex that exhibits strong absorbance at 562 nm. The color intensity is linear with protein concentration over a defined range, allowing quantification by comparison to a standard curve prepared with a protein of known concentration.

The reaction is influenced by temperature, incubation time, and pH. Standard protocols use 37°C for 30 minutes, but elevated temperatures (60°C) can increase sensitivity for low-concentration samples. The assay is endpoint-based, meaning the color develops to a stable maximum and does not require timing after the incubation period, provided the plate is read within 10–15 minutes of removal from the incubator.

Materials and Instrumentation Choices

Reagent Systems

Commercial BCA assay kits (e.g., Thermo Scientific Pierce BCA Protein Assay Kit, Bio-Rad DC Protein Assay) provide pre-formulated reagents that ensure batch-to-batch consistency. The working reagent is prepared by mixing reagent A (containing BCA, sodium carbonate, sodium bicarbonate, and sodium tartrate in 0.1 M sodium hydroxide) with reagent B (4% cupric sulfate pentahydrate) in a 50:1 ratio (A:B). This mixture is stable for approximately one day at room temperature.

For laboratories preparing reagents in-house, the following formulations are standard:

• Reagent A: 1% BCA (sodium salt), 2% Na₂CO₃·H₂O, 0.16% Na₂C₄H₄O₆ (sodium tartrate), 0.4% NaOH, 0.95% NaHCO₃, adjusted to pH 11.25
• Reagent B: 4% CuSO₄·5H₂O in water

Standard Protein Selection

Bovine serum albumin (BSA) is the most common standard because it is inexpensive, readily available, and produces a linear response in the BCA assay. However, BSA may overestimate protein concentration in samples with different amino acid compositions because it contains relatively high levels of cysteine, cystine, and tryptophan. Bovine gamma globulin (BGG) is an alternative standard that more closely matches the amino acid profile of many antibody preparations. For samples of unknown composition, using both standards and comparing results can reveal systematic bias.

Instrumentation

The assay can be performed in either a 96-well microplate format or a standard cuvette format. Microplate readers equipped with a 562 nm filter or monochromator are preferred for high-throughput applications, requiring only 25 µL of sample per well. Cuvette-based spectrophotometers require 1 mL of sample and are suitable when sample volume is not limiting. Both formats require the instrument to be calibrated with a blank and to have a linear absorbance range of 0.1–2.0 AU.

Sample Preparation Considerations

Samples should be clarified by centrifugation (10,000 × g for 10 min at 4°C) to remove particulates that could scatter light and inflate absorbance readings. For cell lysates, sonication or homogenization should be followed by centrifugation. The BCA assay is compatible with common lysis buffers containing up to 5% SDS, 5% Triton X-100, 5% Tween-20, or 5% NP-40, but reducing agents (dithiothreitol, β-mercaptoethanol) at concentrations above 1 mM will interfere by reducing Cu²⁺ directly [1].

Controls and Standards

Blank

The blank consists of the same buffer or solution used to dissolve the protein samples, without any protein. This accounts for absorbance contributed by the buffer components and the BCA reagents themselves. For cell lysates, the blank should contain the lysis buffer at the same concentration as in the samples.

Standard Curve

Prepare a dilution series of the standard protein (BSA or BGG) covering the expected concentration range. For the standard protocol (20–2,000 µg/mL), a typical seven-point curve includes:

• 2,000 µg/mL
• 1,500 µg/mL
• 1,000 µg/mL
• 750 µg/mL
• 500 µg/mL
• 250 µg/mL
• 125 µg/mL
• 25 µg/mL
• 0 µg/mL (blank)

Each standard should be prepared in the same buffer as the samples to account for buffer-specific effects on color development. Prepare a stock solution of 2 mg/mL BSA in the sample buffer, then perform serial dilutions. For example, to prepare 1 mL of 1,500 µg/mL, mix 750 µL of 2 mg/mL stock with 250 µL of buffer.

Sample Replicates

Each sample should be assayed in at least duplicate, preferably triplicate. The coefficient of variation (CV) between replicates should be less than 10% for reliable quantification. If the CV exceeds 15%, the sample should be re-assayed after dilution or clarification.

Quality Control Samples

Include a known concentration of a control protein (e.g., a purified protein of known concentration) in each assay to verify accuracy. The measured concentration should fall within 10% of the expected value.

Conceptual Workflow

Step 1: Prepare Standards and Samples

1. Prepare BSA standards in the same buffer as the samples, covering the range 25–2,000 µg/mL.
2. Dilute unknown samples if necessary to fall within the standard curve range. A preliminary assay using a 1:10 dilution can help determine the appropriate dilution factor.
3. For each standard and sample, pipette 25 µL into a 96-well microplate (or 1 mL into a cuvette). Include a blank (buffer only) and at least two replicates per condition.

Step 2: Prepare and Add Working Reagent

1. Calculate the total volume of working reagent needed: (number of standards + number of samples + blank) × number of replicates × 200 µL (for microplate) or 2 mL (for cuvette). Add 10% excess.
2. Mix reagent A and reagent B in a 50:1 ratio. For example, for 10 mL of working reagent, combine 9.8 mL of reagent A with 0.2 mL of reagent B. Mix gently to avoid foaming.
3. Add 200 µL of working reagent to each well (or 2 mL to each cuvette). Mix by pipetting or gentle shaking.

Step 3: Incubate

1. Cover the plate or cuvettes to prevent evaporation.
2. Incubate at 37°C for 30 minutes (standard protocol) or at 60°C for 30 minutes (enhanced sensitivity protocol). For room temperature incubation, allow 2 hours.
3. After incubation, allow the plate to cool to room temperature for 5–10 minutes before reading.

Step 4: Measure Absorbance

1. Set the microplate reader to 562 nm. If using a filter-based reader, a 560–570 nm filter is acceptable.
2. Blank the instrument using the blank well (or cuvette).
3. Read the absorbance of all standards and samples within 15 minutes of removing from the incubator, as the color may continue to develop slowly at room temperature.

Step 5: Generate Standard Curve and Calculate Concentrations

1. Subtract the blank absorbance from all standard and sample readings.
2. Plot the corrected absorbance (y-axis) versus the standard protein concentration (x-axis) in µg/mL.
3. Perform linear regression on the data points. The standard curve should have an R² value of at least 0.98. If the curve is nonlinear at high concentrations, exclude the highest point(s) and re-fit.
4. Use the equation of the line (y = mx + b) to calculate the concentration of each unknown sample: concentration = (absorbance − b) / m.
5. Multiply by the dilution factor if the sample was diluted prior to assay.

Quality Checks

Linearity of Standard Curve

The standard curve should be linear over the range used. For the BCA assay, linearity typically extends from 25 to 2,000 µg/mL when using the standard protocol. If the curve shows significant curvature (R² < 0.98), check for pipetting errors, incorrect reagent ratios, or expired reagents. A quadratic fit may be acceptable for some applications, but linear regression is preferred for simplicity and accuracy.

Replicate Consistency

Calculate the mean and standard deviation for each set of replicates. The CV should be below 10%. High variability may indicate uneven pipetting, incomplete mixing, or bubbles in the wells. For cuvette-based assays, ensure the cuvette is clean and free of scratches.

Recovery of Spiked Control

Add a known amount of standard protein to a sample and measure the total protein concentration. The recovery should be 90–110% of the expected value. Low recovery suggests interference from sample components; high recovery may indicate overestimation due to non-protein reducing agents.

Absorbance Range

Sample absorbance values should fall within the linear range of the spectrophotometer (typically 0.1–2.0 AU). Values below 0.1 AU are near the detection limit and may be unreliable; values above 2.0 AU may exceed the instrument's linear range and require dilution.

Interpretation of Results

Calculating Protein Concentration

The protein concentration of an unknown sample is determined by interpolating its corrected absorbance on the standard curve. For example, if the standard curve equation is y = 0.0012x + 0.05 (where y is absorbance and x is concentration in µg/mL), and a sample has a corrected absorbance of 0.65, then:

x = (0.65 − 0.05) / 0.0012 = 500 µg/mL

If the sample was diluted 1:5 before assay, the original concentration is 500 × 5 = 2,500 µg/mL (2.5 mg/mL).

Reporting Units

Protein concentration is typically reported in µg/mL or mg/mL. For purified proteins, concentration can be converted to molarity using the molecular weight. For example, a 1 mg/mL solution of a 50 kDa protein corresponds to 20 µM.

Comparing to Other Methods

The BCA assay generally provides more accurate results than the Bradford assay for complex protein mixtures, particularly those containing small proteins or peptides that may not bind Coomassie dye effectively [3]. However, the BCA assay is more susceptible to interference from reducing agents and chelators. For samples with known interferences, the Bradford assay or a direct UV absorbance method (A₂₈₀) may be more appropriate.

Troubleshooting

Limitations

Interfering Substances

The BCA assay is sensitive to several common laboratory reagents. Reducing agents (dithiothreitol, β-mercaptoethanol, TCEP) at concentrations above 1 mM will reduce Cu²⁺ directly, producing falsely elevated readings. Chelating agents (EDTA, EGTA) at concentrations above 10 mM can sequester Cu²⁺ and inhibit color development. High concentrations of Tris (>50 mM), ammonium sulfate (>1 M), or glycine (>100 mM) can also interfere. For samples containing these substances, dialysis or buffer exchange is recommended before assay.

Protein-to-Protein Variability

Different proteins produce different color yields per unit mass because the BCA assay responds to peptide bonds and specific amino acid residues. A protein rich in cysteine and tryptophan will produce a stronger signal than a protein poor in these residues. Using BSA as a standard may overestimate or underestimate the concentration of other proteins by 10–30%. For accurate quantification of a specific protein, a standard curve prepared with the purified target protein is ideal.

Detection Range

The standard BCA assay has a detection range of 20–2,000 µg/mL. For samples with concentrations below 20 µg/mL, the enhanced protocol (60°C incubation) can extend the range to approximately 5 µg/mL, but accuracy decreases at the lower end. For very dilute samples, alternative methods such as fluorescence-based assays (e.g., Qubit) may be more appropriate.

Endpoint Nature

The BCA assay is an endpoint assay, meaning the color develops to a stable maximum and does not change significantly after cooling. However, if the plate is left at room temperature for more than 30 minutes after incubation, the color may continue to develop slowly, leading to overestimation. Consistent timing between incubation and reading is essential for reproducibility.

Documentation and Reporting

Laboratory Notebook Entry

Record the following information for each BCA assay:

• Date and operator name
• Kit manufacturer and lot number (or in-house reagent preparation details)
• Standard protein type and concentration range
• Sample names and dilution factors
• Incubation temperature and time
• Absorbance readings for all standards, blanks, and samples
• Standard curve equation and R² value
• Calculated protein concentrations for each sample
• Any deviations from the standard protocol

Data Analysis File

Maintain an electronic spreadsheet containing:

• Raw absorbance data
• Blank-corrected values
• Standard curve plot with regression statistics
• Calculated concentrations with dilution factors
• CV for each sample set
• Quality control results (recovery of spiked control)

Reporting in Publications

When reporting protein concentrations determined by BCA assay, include:

• The assay method (BCA) and kit manufacturer
• The standard protein used (e.g., BSA)
• The number of replicates
• The standard curve range and R² value
• Any sample dilutions performed
• The incubation temperature and time

Biosafety Considerations

The BCA assay is a routine biochemical procedure that does not involve the propagation of microorganisms. However, the protein samples being quantified may originate from biological sources. For samples derived from BSL-1 organisms (e.g., non-pathogenic Escherichia coli, Bacillus subtilis), standard laboratory practices apply: wear gloves and a lab coat, work on a clean bench, and dispose of tips and tubes in biohazard waste [6]. For samples from higher-risk organisms, appropriate containment and inactivation procedures must be followed before the assay.

The BCA reagents themselves are corrosive (sodium hydroxide in reagent A) and should be handled with gloves. In case of skin contact, wash thoroughly with water. The working reagent should be prepared in a chemical fume hood if large volumes are handled.

For samples containing recombinant or synthetic nucleic acids, follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [7]. The BCA assay does not involve the manipulation of nucleic acids, but the source material may require appropriate containment.

Frequently Asked Questions

1. Can I use the BCA assay for samples containing detergents?

Yes, the BCA assay is compatible with many detergents at typical working concentrations. SDS up to 5%, Triton X-100 up to 5%, Tween-20 up to 5%, and NP-40 up to 5% do not significantly interfere. However, some detergents (e.g., CHAPS at >1%) may cause precipitation or color interference. Always include a buffer-only blank containing the same detergent concentration as the samples.

2. Why is my standard curve nonlinear at high concentrations?

Nonlinearity at high concentrations (above 1,500–2,000 µg/mL) is common in the BCA assay and may result from saturation of the Cu²⁺ reduction reaction or from the inner filter effect at high absorbance values. To address this, either exclude the highest standard points and fit only the linear portion, or prepare a separate standard curve with a lower concentration range (e.g., 25–1,000 µg/mL) for samples expected to be in that range.

3. How do I choose between BSA and BGG as the standard?

Use BSA as the standard for most applications because it is inexpensive and widely available. Use BGG when quantifying antibodies or other immunoglobulins, as BGG more closely matches their amino acid composition. For samples of unknown composition, assay against both standards and report the range of values. Some commercial kits provide both standards for this purpose.

4. Can I reuse the standard curve from a previous assay?

No, a new standard curve must be prepared for each assay. The BCA reaction is sensitive to slight variations in incubation temperature, incubation time, reagent preparation, and instrument calibration. Reusing a standard curve from a previous assay introduces systematic error that can exceed 20%. Always include fresh standards with each assay run.

References and Further Reading

1. Stevenson D, MacPhee CE, Stanley-Wall N. Microplate-based quantification of poly-γ-glutamic acid levels in biofilm samples. 2026. PubMed ID: 42273085. https://pubmed.ncbi.nlm.nih.gov/42273085/ — Describes a microplate-based quantification method using absorbance measurements, relevant to understanding standard curve generation in plate-based assays.

2. Zhong H, Shen X, Yang H. A Cell-Based Protocol to Assess Manganese Content and Relative Transport Activity of Manganese Transporters. 2026. PubMed ID: 42111699. https://pubmed.ncbi.nlm.nih.gov/42111699/ — Provides a framework for using standard curves in cell-based quantification assays.

3. French S, Da Silva R, Have MT, et al. Quantifying venom in African snakes: Insights into protein content, yield and body size associations. 2026. PubMed ID: 41853099. https://pubmed.ncbi.nlm.nih.gov/41853099/ — Validates the BCA assay as the most accurate method for quantifying complex protein mixtures compared to Bradford and NanoDrop methods.

4. Hopkins G, Sheffield D, Barlow H, et al. Impact of liquid dosing and associated cell 'drowning' in a 3D human bronchial epithelial model used for protease exposure studies. 2026. PubMed ID: 42299333. https://pubmed.ncbi.nlm.nih.gov/42299333/ — Demonstrates use of protein quantification in cell-based exposure studies.

5. Rama Varma A, Borris F, Kant P, et al. Long-Term Stability of Bacterial Extracellular Vesicles Stored at Different Temperatures. 2026. PubMed ID: 42253711. https://pubmed.ncbi.nlm.nih.gov/42253711/ — Reports that EV protein concentration measured by BCA assay remains stable under various storage conditions.

6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. 2020. https://www.cdc.gov/labs/bmbl/index.html — Authoritative principles for risk assessment and containment in microbiological laboratories.

7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/ — Framework for biosafety in recombinant nucleic acid research.

8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. https://www.ncbi.nlm.nih.gov/books/ — Searchable collection of authoritative biomedical methods references.

Related Articles

• How to Calculate the Concentration of Protein Using the Bradford Assay
• How to Calculate DNA Concentration from Absorbance Readings
• How to Calculate Rf Values in Protein Electrophoresis
• How to Calculate Transformation Efficiency
• How to Calculate Molarity of a DNA Solution
• How to Calculate the Annealing Temperature for PCR